Alison Templeton
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 1%
- Molecular Biology top 10%
- Cancer Research top 2%
- Infectious Diseases top 10%
- Co-authors
- Tony MokSerban GhiorghiuYi‐Long WuVassiliki A. PapadimitrakopoulouHelen MannWillemijn S.M.E. TheelenMarcelo MarottiChee Khoon Lee
- Topics
- Lung Cancer Treatments and Mutations (5 papers)Colorectal Cancer Treatments and Studies (4 papers)SARS-CoV-2 and COVID-19 Research (3 papers)
- Partner nations
- United KingdomUnited StatesChina
In The Last Decade
Alison Templeton
14 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Pulmonary and Respiratory Medicine 2.4k
- Oncology 1.9k
- Molecular Biology 759
- Cancer Research 681
- Infectious Diseases 145
Countries citing papers authored by Alison Templeton
This map shows the geographic impact of Alison Templeton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Templeton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Templeton more than expected).
Fields of papers citing papers by Alison Templeton
This network shows the impact of papers produced by Alison Templeton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Templeton. The network helps show where Alison Templeton may publish in the future.
Co-authorship network of co-authors of Alison Templeton
This figure shows the co-authorship network connecting the top 25 collaborators of Alison Templeton. A scholar is included among the top collaborators of Alison Templeton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Templeton. Alison Templeton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 3 | |
| 3 | Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trialbreakdown → | 127 |
| 4 | Osimertinib or platinum–pemetrexed in EGFR T790M–positive lung cancer | 290 |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 5 | |
| 8 | Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancerbreakdown → | 2369 |
| 9 | 7 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 3 | |
| 13 | 57 | |
| 14 | 24 |
About Alison Templeton
Alison Templeton is a scholar working on Oncology, Critical Care and Intensive Care Medicine and Infectious Diseases, having authored 14 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.4k citations), Oncology (1.9k citations) and Cancer Research (681 citations). Alison Templeton has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include Tony Mok, Serban Ghiorghiu, Yi‐Long Wu, Vassiliki A. Papadimitrakopoulou, Helen Mann, Willemijn S.M.E. Theelen, Marcelo Marotti, Chee Khoon Lee, Suresh S. Ramalingam and Hiroaki Akamatsu. Their work appears in journals such as New England Journal of Medicine, The Journal of Infectious Diseases and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.